These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Mutational analysis of the structural organization of polyglutamine aggregates. Thakur AK; Wetzel R Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17014-9. PubMed ID: 12444250 [TBL] [Abstract][Full Text] [Related]
8. Reconsidering the mechanism of polyglutamine peptide aggregation. Lee CC; Walters RH; Murphy RM Biochemistry; 2007 Nov; 46(44):12810-20. PubMed ID: 17929830 [TBL] [Abstract][Full Text] [Related]
9. Effects of chain length on the aggregation of model polyglutamine peptides: molecular dynamics simulations. Marchut AJ; Hall CK Proteins; 2007 Jan; 66(1):96-109. PubMed ID: 17068817 [TBL] [Abstract][Full Text] [Related]
10. Unaided trifluoroacetic acid pretreatment solubilizes polyglutamine peptides and retains their biophysical properties of aggregation. Burra G; Thakur AK Anal Biochem; 2016 Feb; 494():23-30. PubMed ID: 26514067 [TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of polyglutamine disorders: aggregation revisited. Michalik A; Van Broeckhoven C Hum Mol Genet; 2003 Oct; 12 Spec No 2():R173-86. PubMed ID: 14504263 [TBL] [Abstract][Full Text] [Related]
12. Screening for modulators of aggregation with a microplate elongation assay. Berthelier V; Wetzel R Methods Enzymol; 2006; 413():313-25. PubMed ID: 17046403 [TBL] [Abstract][Full Text] [Related]
13. polyglutamine aggregation nucleation: thermodynamics of a highly unfavorable protein folding reaction. Bhattacharyya AM; Thakur AK; Wetzel R Proc Natl Acad Sci U S A; 2005 Oct; 102(43):15400-5. PubMed ID: 16230628 [TBL] [Abstract][Full Text] [Related]
14. Solubilization and disaggregation of polyglutamine peptides. Chen S; Wetzel R Protein Sci; 2001 Apr; 10(4):887-91. PubMed ID: 11274480 [TBL] [Abstract][Full Text] [Related]
15. The pathogenic agent in Drosophila models of 'polyglutamine' diseases. McLeod CJ; O'Keefe LV; Richards RI Hum Mol Genet; 2005 Apr; 14(8):1041-8. PubMed ID: 15757976 [TBL] [Abstract][Full Text] [Related]
16. Surface plasmon resonance characterization of specific binding of polyglutamine aggregation inhibitors to the expanded polyglutamine stretch. Okamoto Y; Nagai Y; Fujikake N; Akiko Popiel H; Yoshioka T; Toda T; Inui T Biochem Biophys Res Commun; 2009 Jan; 378(3):634-9. PubMed ID: 19061859 [TBL] [Abstract][Full Text] [Related]
17. Characterization of intracellular aggregates using fluorescently-tagged polyglutamine-expanded androgen receptor. Panet-Raymond V; Gottlieb B; Beitel LK; Schipper H; Timiansky M; Pinsky L; Trifiro MA Neurotox Res; 2001 Jul; 3(3):259-75. PubMed ID: 15111251 [TBL] [Abstract][Full Text] [Related]
18. Characterizing the conformational ensemble of monomeric polyglutamine. Wang X; Vitalis A; Wyczalkowski MA; Pappu RV Proteins; 2006 May; 63(2):297-311. PubMed ID: 16299774 [TBL] [Abstract][Full Text] [Related]
19. [Therapeutic strategies for the polyglutamine diseases]. Nagai Y; Popiel HA; Fujikake N; Toda T Brain Nerve; 2007 Apr; 59(4):393-404. PubMed ID: 17447526 [TBL] [Abstract][Full Text] [Related]
20. An assay for detecting nanogram levels of proteolytic enzymes. Koritsas VM; Atkinson HJ Anal Biochem; 1995 May; 227(1):22-6. PubMed ID: 7668384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]